TrialBlood cancer journal2016

Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial.

J R Jones et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.